{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:31:25Z","timestamp":1761395485409},"reference-count":0,"publisher":"Portico","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2019.55.5.2962947","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:00:27Z","timestamp":1558090827000},"page":"297","source":"Crossref","is-referenced-by-count":5,"title":["Dolutegravir plus lamivudine dual therapy - a new option for\ninitial antiretroviral therapy"],"prefix":"10.3730","volume":"55","author":[{"family":"Fida, M.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Rizza, S.A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Temesgen, Z.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2019]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:45:00Z","timestamp":1685454300000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dctg4c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2019.55.5.2962947","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}